Industry Research Reports
Home > Reports > Chemical & Material > Global Astatine-211 Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Astatine-211 Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-07-31
Pages: 122 Pages
Report ld: 4810730
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Astatine-211 Market Size(US$)
CAGR 2025-2031
37.8%
Market Size,2031
USD 219
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 32 million
Market Forecast in 2031(Value)
US$ 219 million
CAGR
37.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Astatine-211 market is projected to grow from US$ 5.9 million in 2024 to US$ 219 million by 2031, at a CAGR of 37.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Astatine-211 is an isotope of the chemical element astatine (symbol: At) with extremely high radioactivity. The half-life of astatine-211 is 7.2 hours, which is a relatively long-lived astatine isotope. Astatine-211 is an alpha particle emitter that continuously releases alpha particles consisting of two protons and two neutrons. The chemical properties of astatine are similar to those of other halogens, such as iodine, but the radioactivity of astatine-211 greatly limits the study of its chemical properties. It can be used to form chemical bonds with metal organic derivatives (such as tin) or carborane precursors, combined with molecular carriers targeting malignant tumor cell groups, to prepare alpha nuclide targeted therapeutic drugs.
Global key players of Astatine-211 include Ionetix, NIDC (DOE IP), Alpha Fusion, etc. The top three players hold a share about 99%. United States is the largest market, and has a share about 97%.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Astatine-211 market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Ionetix
- NIDC (DOE IP)
- Alpha Fusion Inc
- RIKEN
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Produced by Bombardment of Bismuth
- Others
Segment by Application
- Scientific Research
- Cancer Therapy
CHAPTER OUTLINE
Chapter 1: Defines the Astatine-211 study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Astatine-211: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Astatine-211 Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Produced by Bombardment of Bismuth
1.2.3 Others
1.3 Market Segmentation by Application
1.3.1 Global Astatine-211 Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Scientific Research
1.3.3 Cancer Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Astatine-211 Revenue Estimates and Forecasts 2020-2031
2.2 Global Astatine-211 Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Astatine-211 Sales Estimates and Forecasts 2020-2031
2.4 Global Astatine-211 Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Astatine-211 Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Japan
4 Competition by Manufacturers
4.1 Global Astatine-211 Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Astatine-211 Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Produced by Bombardment of Bismuth Market Size by Manufacturers
4.5.2 Others Market Size by Manufacturers
4.6 Global Astatine-211 Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Astatine-211 Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Astatine-211 Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Astatine-211 Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Astatine-211 Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Astatine-211 Sales and Revenue by Type (2020-2031)
7.4 North America Astatine-211 Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Astatine-211 Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Astatine-211 Sales and Revenue by Type (2020-2031)
8.4 Europe Astatine-211 Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Astatine-211 Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Astatine-211 Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Astatine-211 Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Astatine-211 Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Astatine-211 Sales and Revenue by Type (2020-2031)
10.4 Central and South America Astatine-211 Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Astatine-211 Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Astatine-211 Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Astatine-211 Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Astatine-211 Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Ionetix
12.1.1 Ionetix Corporation Information
12.1.2 Ionetix Business Overview
12.1.3 Ionetix Astatine-211 Product Models, Descriptions and Specifications
12.1.4 Ionetix Astatine-211 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Ionetix Astatine-211 Sales by Product in 2024
12.1.6 Ionetix Astatine-211 Sales by Application in 2024
12.1.7 Ionetix Astatine-211 Sales by Geographic Area in 2024
12.1.8 Ionetix Astatine-211 SWOT Analysis
12.1.9 Ionetix Recent Developments
12.2 NIDC (DOE IP)
12.2.1 NIDC (DOE IP) Corporation Information
12.2.2 NIDC (DOE IP) Business Overview
12.2.3 NIDC (DOE IP) Astatine-211 Product Models, Descriptions and Specifications
12.2.4 NIDC (DOE IP) Astatine-211 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 NIDC (DOE IP) Astatine-211 Sales by Product in 2024
12.2.6 NIDC (DOE IP) Astatine-211 Sales by Application in 2024
12.2.7 NIDC (DOE IP) Astatine-211 Sales by Geographic Area in 2024
12.2.8 NIDC (DOE IP) Astatine-211 SWOT Analysis
12.2.9 NIDC (DOE IP) Recent Developments
12.3 Alpha Fusion Inc
12.3.1 Alpha Fusion Inc Corporation Information
12.3.2 Alpha Fusion Inc Business Overview
12.3.3 Alpha Fusion Inc Astatine-211 Product Models, Descriptions and Specifications
12.3.4 Alpha Fusion Inc Astatine-211 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Alpha Fusion Inc Astatine-211 Sales by Product in 2024
12.3.6 Alpha Fusion Inc Astatine-211 Sales by Application in 2024
12.3.7 Alpha Fusion Inc Astatine-211 Sales by Geographic Area in 2024
12.3.8 Alpha Fusion Inc Astatine-211 SWOT Analysis
12.3.9 Alpha Fusion Inc Recent Developments
12.4 RIKEN
12.4.1 RIKEN Corporation Information
12.4.2 RIKEN Business Overview
12.4.3 RIKEN Astatine-211 Product Models, Descriptions and Specifications
12.4.4 RIKEN Astatine-211 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 RIKEN Astatine-211 Sales by Product in 2024
12.4.6 RIKEN Astatine-211 Sales by Application in 2024
12.4.7 RIKEN Astatine-211 Sales by Geographic Area in 2024
12.4.8 RIKEN Astatine-211 SWOT Analysis
12.4.9 RIKEN Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Astatine-211 Industry Chain
13.2 Astatine-211 Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Astatine-211 Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Astatine-211 Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Astatine-211 Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Astatine-211 Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Astatine-211 Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Astatine-211 Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Astatine-211 Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Astatine-211 Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Astatine-211 Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Astatine-211 Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (mCi)
Table 7. Global Astatine-211 Sales by Region (2020-2025) & (mCi)
Table 8. Global Astatine-211 Sales by Region (2026-2031) & (mCi)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Astatine-211 Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (mCi)
Table 11. Global Astatine-211 Production by Region (2020-2025) & (mCi)
Table 12. Global Astatine-211 Production by Region (2026-2031) & (mCi)
Table 13. Global Astatine-211 Sales by Manufacturers (2020-2025) & (mCi)
Table 14. Global Astatine-211 Sales Share by Manufacturers (2020-2025)
Table 15. Global Astatine-211 Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Astatine-211 Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Astatine-211 by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Astatine-211 as of 2024)
Table 19. Global Astatine-211 Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Astatine-211 Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/mCi)
Table 21. Key Manufacturers Astatine-211 Manufacturing Base and Headquarters
Table 22. Global Astatine-211 Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Astatine-211 Sales by Type (2020-2025) & (mCi)
Table 26. Global Astatine-211 Sales by Type (2026-2031) & (mCi)
Table 27. Global Astatine-211 Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Astatine-211 Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Astatine-211 ASP by Type (2020-2031) & (US$/mCi)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Astatine-211 Sales by Application (2020-2025) & (mCi)
Table 32. Global Astatine-211 Sales by Application (2026-2031) & (mCi)
Table 33. Astatine-211 High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Astatine-211 Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Astatine-211 Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Astatine-211 ASP by Application (2020-2031) & (US$/mCi)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Astatine-211 Growth Accelerators and Market Barriers
Table 40. North America Astatine-211 Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Astatine-211 Sales (mCi) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Astatine-211 Growth Accelerators and Market Barriers
Table 43. Europe Astatine-211 Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Astatine-211 Sales (mCi) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Astatine-211 Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Astatine-211 Sales (mCi) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Astatine-211 Growth Accelerators and Market Barriers
Table 48. Southeast Asia Astatine-211 Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Astatine-211 Investment Opportunities and Key Challenges
Table 50. Central and South America Astatine-211 Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Astatine-211 Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Astatine-211 Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Ionetix Corporation Information
Table 54. Ionetix Description and Major Businesses
Table 55. Ionetix Product Models, Descriptions and Specifications
Table 56. Ionetix Capacity, Sales (mCi), Revenue (US$ Million), Price (US$/mCi) and Gross Margin (2020-2025)
Table 57. Ionetix Sales Value Proportion by Product in 2024
Table 58. Ionetix Sales Value Proportion by Application in 2024
Table 59. Ionetix Sales Value Proportion by Geographic Area in 2024
Table 60. Ionetix Astatine-211 SWOT Analysis
Table 61. Ionetix Recent Developments
Table 62. NIDC (DOE IP) Corporation Information
Table 63. NIDC (DOE IP) Description and Major Businesses
Table 64. NIDC (DOE IP) Product Models, Descriptions and Specifications
Table 65. NIDC (DOE IP) Capacity, Sales (mCi), Revenue (US$ Million), Price (US$/mCi) and Gross Margin (2020-2025)
Table 66. NIDC (DOE IP) Sales Value Proportion by Product in 2024
Table 67. NIDC (DOE IP) Sales Value Proportion by Application in 2024
Table 68. NIDC (DOE IP) Sales Value Proportion by Geographic Area in 2024
Table 69. NIDC (DOE IP) Astatine-211 SWOT Analysis
Table 70. NIDC (DOE IP) Recent Developments
Table 71. Alpha Fusion Inc Corporation Information
Table 72. Alpha Fusion Inc Description and Major Businesses
Table 73. Alpha Fusion Inc Product Models, Descriptions and Specifications
Table 74. Alpha Fusion Inc Capacity, Sales (mCi), Revenue (US$ Million), Price (US$/mCi) and Gross Margin (2020-2025)
Table 75. Alpha Fusion Inc Sales Value Proportion by Product in 2024
Table 76. Alpha Fusion Inc Sales Value Proportion by Application in 2024
Table 77. Alpha Fusion Inc Sales Value Proportion by Geographic Area in 2024
Table 78. Alpha Fusion Inc Astatine-211 SWOT Analysis
Table 79. Alpha Fusion Inc Recent Developments
Table 80. RIKEN Corporation Information
Table 81. RIKEN Description and Major Businesses
Table 82. RIKEN Product Models, Descriptions and Specifications
Table 83. RIKEN Capacity, Sales (mCi), Revenue (US$ Million), Price (US$/mCi) and Gross Margin (2020-2025)
Table 84. RIKEN Sales Value Proportion by Product in 2024
Table 85. RIKEN Sales Value Proportion by Application in 2024
Table 86. RIKEN Sales Value Proportion by Geographic Area in 2024
Table 87. RIKEN Astatine-211 SWOT Analysis
Table 88. RIKEN Recent Developments
Table 89. Key Raw Materials Distribution
Table 90. Raw Materials Key Suppliers
Table 91. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 92. Milestones in Production Technology Evolution
Table 93. Distributors List
Table 94. Market Trends and Market Evolution
Table 95. Market Drivers and Opportunities
Table 96. Market Challenges, Risks, and Restraints
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Astatine-211 Product Picture
Figure 2. Global Astatine-211 Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Produced by Bombardment of Bismuth Product Picture
Figure 4. Others Product Picture
Figure 5. Global Astatine-211 Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Scientific Research
Figure 7. Cancer Therapy
Figure 8. Astatine-211 Report Years Considered
Figure 9. Global Astatine-211 Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 11. Global Astatine-211 Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Astatine-211 Revenue Market Share by Region (2020-2031)
Figure 13. Global Astatine-211 Sales (2020-2031) & (mCi)
Figure 14. Global Astatine-211 Sales (CAGR) by Region (2020-2031) (mCi)
Figure 15. Global Astatine-211 Sales Market Share by Region (2020-2031)
Figure 16. Global Astatine-211 Capacity, Production and Utilization (2020-2031) & (mCi)
Figure 17. Global Astatine-211 Production Trend by Region (2020-2031) (mCi)
Figure 18. Global Astatine-211 Production Market Share by Region (2020-2031)
Figure 19. Production Capacity Enablers & Constraints
Figure 20. Astatine-211 Production Growth Rate in North America (2020-2031) & (mCi)
Figure 21. Astatine-211 Production Growth Rate in Japan (2020-2031) & (mCi)
Figure 22. Top 5 and Top 10 Manufacturers Astatine-211 Sales Volume Market Share in 2024
Figure 23. Global Astatine-211 Revenue Market Share Ranking (2024)
Figure 24. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 25. Produced by Bombardment of Bismuth Revenue Market Share by Manufacturer in 2024
Figure 26. Others Revenue Market Share by Manufacturer in 2024
Figure 27. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 28. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 29. Global Astatine-211 Sales Market Share by Type (2020-2031)
Figure 30. Global Astatine-211 Revenue Market Share by Type (2020-2031)
Figure 31. Global Astatine-211 Sales Market Share by Application (2020-2031)
Figure 32. Global Astatine-211 Revenue Market Share by Application (2020-2031)
Figure 33. North America Astatine-211 Sales YoY (2020-2031) & (mCi)
Figure 34. North America Astatine-211 Revenue YoY (2020-2031) & (US$ Million)
Figure 35. North America Top 5 Manufacturers Astatine-211 Sales Revenue (US$ Million) in 2024
Figure 36. North America Astatine-211 Sales Volume (mCi) by Type (2020- 2031)
Figure 37. North America Astatine-211 Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 38. North America Astatine-211 Sales Volume (mCi) by Application (2020-2031)
Figure 39. North America Astatine-211 Sales Revenue (US$ Million) by Application (2020-2031)
Figure 40. US Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 41. Canada Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 42. Mexico Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 43. Europe Astatine-211 Sales YoY (2020-2031) & (mCi)
Figure 44. Europe Astatine-211 Revenue YoY (2020-2031) & (US$ Million)
Figure 45. Europe Top 5 Manufacturers Astatine-211 Sales Revenue (US$ Million) in 2024
Figure 46. Europe Astatine-211 Sales Volume (mCi) by Type (2020-2031)
Figure 47. Europe Astatine-211 Sales Revenue (US$ Million) by Type (2020-2031)
Figure 48. Europe Astatine-211 Sales Volume (mCi) by Application (2020-2031)
Figure 49. Europe Astatine-211 Sales Revenue (US$ Million) by Application (2020-2031)
Figure 50. Germany Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 51. France Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 52. U.K. Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 53. Italy Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 54. Russia Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Astatine-211 Sales YoY (2020-2031) & (mCi)
Figure 56. Asia-Pacific Astatine-211 Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Asia-Pacific Top 8 Manufacturers Astatine-211 Sales Revenue (US$ Million) in 2024
Figure 58. Asia-Pacific Astatine-211 Sales Volume (mCi) by Type (2020- 2031)
Figure 59. Asia-Pacific Astatine-211 Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 60. Asia-Pacific Astatine-211 Sales Volume (mCi) by Application (2020-2031)
Figure 61. Asia-Pacific Astatine-211 Sales Revenue (US$ Million) by Application (2020-2031)
Figure 62. Indonesia Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 63. Japan Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 64. South Korea Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 65. China Taiwan Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 66. India Astatine-211 Revenue (2020-2031) & (US$ Million)
Figure 67. Central and South America Astatine-211 Sales YoY (2020-2031) & (mCi)
Figure 68. Central and South America Astatine-211 Revenue YoY (2020-2031) & (US$ Million)
Figure 69. Central and South America Top 5 Manufacturers Astatine-211 Sales Revenue (US$ Million) in 2024
Figure 70. Central and South America Astatine-211 Sales Volume (mCi) by Type (2021-2031)
Figure 71. Central and South America Astatine-211 Sales Revenue (US$ Million) by Type (2020-2031)
Figure 72. Central and South America Astatine-211 Sales Volume (mCi) by Application (2020-2031)
Figure 73. Central and South America Astatine-211 Sales Revenue (US$ Million) by Application (2020-2031)
Figure 74. Brazil Astatine-211 Revenue (2020-2025) & (US$ Million)
Figure 75. Argentina Astatine-211 Revenue (2020-2025) & (US$ Million)
Figure 76. Middle East, and Africa Astatine-211 Sales YoY (2020-2031) & (mCi)
Figure 77. Middle East and Africa Astatine-211 Revenue YoY (2020-2031) & (US$ Million)
Figure 78. Middle East and Africa Top 5 Manufacturers Astatine-211 Sales Revenue (US$ Million) in 2024
Figure 79. Middle East and Africa Astatine-211 Sales Volume (mCi) by Type (2021-2031)
Figure 80. South America Astatine-211 Sales Revenue (US$ Million) by Type (2020-2031)
Figure 81. Middle East and Africa Astatine-211 Sales Volume (mCi) by Application (2020-2031)
Figure 82. Middle East and Africa Astatine-211 Sales Revenue (US$ Million) by Application (2020-2031)
Figure 83. GCC Countries Astatine-211 Revenue (2020-2025) & (US$ Million)
Figure 84. Turkey Astatine-211 Revenue (2020-2025) & (US$ Million)
Figure 85. Egypt Astatine-211 Revenue (2020-2025) & (US$ Million)
Figure 86. South Africa Astatine-211 Revenue (2020-2025) & (US$ Million)
Figure 87. Astatine-211 Industry Chain Mapping
Figure 88. Regional Astatine-211 Manufacturing Base Distribution (%)
Figure 89. Astatine-211 Production Process
Figure 90. Regional Astatine-211 Production Cost Structure
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Astatine-211 in 2025?
The global market size of Astatine-211 in 2025 was 32 Million USD.
What was the global market size of Astatine-211 in 2031?
What is the annual compound growth rate of the global Astatine-211 market size from 2025 to 2031?
Which companies rank high in the global Astatine-211 market?
Which region is expected to have the highest market share?
Related Reports
Global Astatine-211 Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Astatine-211 market size was US$ 31.97 million in 2025 and is forecast to reach a readjusted size of US$ 293 million by 2032 with a CAGR of 37.8% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 70
USD 4250.00
(Single User License)
Global Astatine-211 Market Research Report 2026
The global Astatine-211 market was valued at US$ 31.97 million in 2025 and is anticipated to reach US$ 293 million by 2032, at a CAGR of 37.8% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 119
USD 2900.00
(Single User License)
Astatine-211- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Astatine-211 was estimated to be worth US$ 31.97 million in 2025 and is projected to reach US$ 293 million, growing at a CAGR of 37.8% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 80
USD 3950.00
(Single User License)
Global Astatine-211 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Astatine-211 market size was US$ 5.9 million in 2024 and is forecast to a readjusted size of US$ 219 million by 2031 with a CAGR of 37.8% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 65
USD 4250.00
(Single User License)
Astatine-211 - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Astatine-211 was estimated to be worth US$ 5.9 million in 2024 and is forecast to a readjusted size of US$ 219 million by 2031 with a CAGR of 37.8% during the forecast period 2025-2031.
Published Date: 2025-05-15
Pages: 89
USD 3950.00
(Single User License)
Global Astatine-211 Market Insights, Forecast to 2031
The global Astatine-211 market is projected to grow from US$ 32 million in 2025 to US$ 219 million by 2031, at a Compound Annual Growth Rate (CAGR) of 37.8% during the forecast period.
Published Date: 2025-05-15
Pages: 127
USD 4900.00
(Single User License)
Global Astatine-211 Market Research Report 2025
The global market for Astatine-211 was valued at US$ 5.9 million in the year 2024 and is projected to reach a revised size of US$ 219 million by 2031, growing at a CAGR of 37.8% during the forecast period.
Published Date: 2025-05-15
Pages: 79
USD 2900.00
(Single User License)
Astatine-211- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Astatine-211 was estimated to be worth US$ 5.9 million in 2024 and is forecast to a readjusted size of US$ 54.3 million by 2031 with a CAGR of 37.8% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 80
USD 3950.00
(Single User License)
Global Astatine-211 Market Research Report 2024
Astatine-211 is an isotope of the chemical element astatine (symbol: At) with extremely high radioactivity. The half-life of astatine-211 is 7.2 hours, which is a relatively long-lived astatine isotope. Astatine-211 is an alpha particle emitter that continuously releases alpha particles consisting of two protons and two neutrons. The chemical properties of astatine are similar to those of other halogens, such as iodine, but the radioactivity of astatine-211 greatly limits the study of its chemical properties. It can be used to form chemical bonds with metal organic derivatives (such as tin) or carborane precursors, combined with molecular carriers targeting malignant tumor cell groups, to prepare alpha nuclide targeted therapeutic drugs.
Published Date: 2024-07-22
Pages: 85
USD 2900.00
(Single User License)
Global and United States Astatine-211 Market Report & Forecast 2024-2030
Astatine-211 is an isotope of the chemical element astatine (symbol: At) with extremely high radioactivity. The half-life of astatine-211 is 7.2 hours, which is a relatively long-lived astatine isotope. Astatine-211 is an alpha particle emitter that continuously releases alpha particles consisting of two protons and two neutrons. The chemical properties of astatine are similar to those of other halogens, such as iodine, but the radioactivity of astatine-211 greatly limits the study of its chemical properties. It can be used to form chemical bonds with metal organic derivatives (such as tin) or carborane precursors, combined with molecular carriers targeting malignant tumor cell groups, to prepare alpha nuclide targeted therapeutic drugs.
Published Date: 2024-07-22
Pages: 98
USD 4350.00
(Single User License)
Global Astatine-211 Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Astatine-211 market size was US$ 31.97 million in 2025 and is forecast to reach a readjusted size of US$ 293 million by 2032 with a CAGR of 37.8% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 70
USD 4250.00 (Single User License)Global Astatine-211 Market Research Report 2026
The global Astatine-211 market was valued at US$ 31.97 million in 2025 and is anticipated to reach US$ 293 million by 2032, at a CAGR of 37.8% from 2026 to 2032.
Published: 2026-01-05
Pages: 119
USD 2900.00 (Single User License)Astatine-211- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Astatine-211 was estimated to be worth US$ 31.97 million in 2025 and is projected to reach US$ 293 million, growing at a CAGR of 37.8% from 2026 to 2032.
Published: 2026-01-05
Pages: 80
USD 3950.00 (Single User License)Global Astatine-211 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Astatine-211 market size was US$ 5.9 million in 2024 and is forecast to a readjusted size of US$ 219 million by 2031 with a CAGR of 37.8% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 65
USD 4250.00 (Single User License)Astatine-211 - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Astatine-211 was estimated to be worth US$ 5.9 million in 2024 and is forecast to a readjusted size of US$ 219 million by 2031 with a CAGR of 37.8% during the forecast period 2025-2031.
Published: 2025-05-15
Pages: 89
USD 3950.00 (Single User License)Global Astatine-211 Market Insights, Forecast to 2031
The global Astatine-211 market is projected to grow from US$ 32 million in 2025 to US$ 219 million by 2031, at a Compound Annual Growth Rate (CAGR) of 37.8% during the forecast period.
Published: 2025-05-15
Pages: 127
USD 4900.00 (Single User License)Global Astatine-211 Market Research Report 2025
The global market for Astatine-211 was valued at US$ 5.9 million in the year 2024 and is projected to reach a revised size of US$ 219 million by 2031, growing at a CAGR of 37.8% during the forecast period.
Published: 2025-05-15
Pages: 79
USD 2900.00 (Single User License)Astatine-211- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Astatine-211 was estimated to be worth US$ 5.9 million in 2024 and is forecast to a readjusted size of US$ 54.3 million by 2031 with a CAGR of 37.8% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 80
USD 3950.00 (Single User License)Global Astatine-211 Market Research Report 2024
Astatine-211 is an isotope of the chemical element astatine (symbol: At) with extremely high radioactivity. The half-life of astatine-211 is 7.2 hours, which is a relatively long-lived astatine isotope. Astatine-211 is an alpha particle emitter that continuously releases alpha particles consisting of two protons and two neutrons. The chemical properties of astatine are similar to those of other halogens, such as iodine, but the radioactivity of astatine-211 greatly limits the study of its chemical properties. It can be used to form chemical bonds with metal organic derivatives (such as tin) or carborane precursors, combined with molecular carriers targeting malignant tumor cell groups, to prepare alpha nuclide targeted therapeutic drugs.
Published: 2024-07-22
Pages: 85
USD 2900.00 (Single User License)Global and United States Astatine-211 Market Report & Forecast 2024-2030
Astatine-211 is an isotope of the chemical element astatine (symbol: At) with extremely high radioactivity. The half-life of astatine-211 is 7.2 hours, which is a relatively long-lived astatine isotope. Astatine-211 is an alpha particle emitter that continuously releases alpha particles consisting of two protons and two neutrons. The chemical properties of astatine are similar to those of other halogens, such as iodine, but the radioactivity of astatine-211 greatly limits the study of its chemical properties. It can be used to form chemical bonds with metal organic derivatives (such as tin) or carborane precursors, combined with molecular carriers targeting malignant tumor cell groups, to prepare alpha nuclide targeted therapeutic drugs.
Published: 2024-07-22
Pages: 98
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now